Prime Therapeutics Newsroom

GradientRule_withspacer

Prime pharmacist receives Distinguished Young Pharmacist Award 

Prime clinical program director Justine Meierhofer is recognized by the Minnesota Pharmacists Association (MPhA). Story

GradientRule_withspacer

News from Prime

Prime Therapeutics finds autoimmune specialty drug spend has doubled, account for 10 percent of drug expenses 

Integrated medical and pharmacy claims data is essential in developing cost management strategies.


Prime Therapeutics intervention associated with fewer high-risk medication refills in Medicare population

Centers for Medicare & Medicaid Services tracks use of high-risk medications as Star metric.


Prime Therapeutics research finds nearly half of members discontinue costly rheumatoid arthritis drug after one year

Prime analyzed members’ use of rheumatoid arthritis (RA) drug tofacitinib (Xeljanz®) to find patterns and adherence behaviors. 


 

 

 

 

 

 

 

 

 

 

 

 

 

Prime in the news


Prime and Walgreens Alliance May Impact Specialty Drug Costs

Specialty Pharmacy Times | September 1, 2016



Prime Therapeutics and Walgreens will merge mail-order specialty pharma businesses

Minneapolis/St. Paul Business Journal | August 29, 2016

GradientRule_withspacer

Prime Insights

Explore drug research, analyses and insights from Prime's pharmacy experts.

Prime Insights

Get in touch

Connect with one of our media experts to learn more about the latest news and trends in the pharmacy benefit management industry.

Email the newsroom team
Sign-up for regular email updates

      Facebook